Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao,Jiang Lan,Chushu Li,Hubing Shi,Jean-Philippe Brosseau,Huanbin Wang,Haojie Lu,Caiyun Fang,Yao Zhang,Lunxi Liang,Xiaolin Zhou,Chaojun Wang,Yu Xue,Yun Cui,Jie Xu
DOI: https://doi.org/10.1038/s41551-019-0402-7
IF: 28.1
2019-04-11
Nature Biomedical Engineering
Abstract:In the version of this Article originally published, ‘palmitoyltransferase ZDHHC3 (DHHC3)’ was incorrectly referred to as an ‘acetyltransferase’ rather than an as an ‘acyltransferase’; this has now been corrected in five instances. In Fig. 3a, the label for the bottom row of the blots was mistakenly written as ‘GAPHD’; it should have read ‘GAPDH’. In the two right-most panels of Fig. 4j, the antibody labels ‘α-PD-L1’ for the reciprocal co-immunoprecipitation of DHHC3 were incorrect; they should have been ‘α-DHHC3’. These errors have been corrected in all versions of the Article.
engineering, biomedical